Tag Archives: FDA notice

HeartStart Automated External Defibrillators AED Philips Healthcare

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese HeartStart Automated External Defibrillators (AED) From Philips Healthcare: Safety Communication – Failure Of An Electrical Component That Could Cause AEDs To Fail To Deliver Appropriate Shock AUDIENCE: Risk Manager, … Continue reading

Share
Posted in Emergency Medicine, FDA 2013, FDA Safety Communication, Healthcare Professionals, Risk Manager | Tagged , , , , , , , , , , | Comments Off on HeartStart Automated External Defibrillators AED Philips Healthcare

Onfi clobazam Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseOnfi (clobazam): Drug Safety Communication – Risk of Serious Skin Reactions AUDIENCE: Neurology, Pharmacy, Dermatology ISSUE: FDA is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare … Continue reading

Share
Posted in Dermatology, FDA 2013, FDA Safety Communication, Neurology, Pharmacy | Tagged , , , , , , , , | Comments Off on Onfi clobazam Drug Safety Communication

Rosiglitazone containing Diabetes Medicines Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseRosiglitazone-containing Diabetes Medicines: Drug Safety Communication – Removal of Some Prescribing and Dispensing Restrictionsincluding Avandia, Avandamet, Avandaryl, and generics AUDIENCE: Family Care, Endocrinology, Cardiology ISSUE: FDA has determined that recent … Continue reading

Share
Posted in Cardiology, Endocrinology, Family Practice, FDA 2013, FDA Notice | Tagged , , , , , , , , , , , | Comments Off on Rosiglitazone containing Diabetes Medicines Drug Safety Communication

Meridian Medical Technologies Auto-Injectors Extension of Expiration Dates

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseMeridian Medical Technologies Auto-Injectors: Extension of Expiration Dates including Auto-Injectors for Atropen (atropine)DuoDote (atropine/pralidoxime chloride)morphine sulfatepralidoxime chloridediazepam AUDIENCE: Emergency Medicine, Pharmacy ISSUE: FDA is aware of a disruption in supply to … Continue reading

Share
Posted in Emergency Medicine, FDA 2013, FDA Notice, Pharmacy | Tagged , , , , , , , , , | Comments Off on Meridian Medical Technologies Auto-Injectors Extension of Expiration Dates

Lexiscan regadenoson and Adenoscan adenosine Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseLexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication – Rare but Serious Risk of Heart Attack and Death AUDIENCE: Cardiology, Pharmacy, Radiology ISSUE: The FDA is warning health care professionals … Continue reading

Share
Posted in Cardiology, FDA 2013, FDA Safety Communication, Pharmacy, Radiology | Tagged , , , , , , , , , , , | Comments Off on Lexiscan regadenoson and Adenoscan adenosine Drug Safety Communication

St Jude Amplatzer Atrial Septal Occluder ASO Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseSt. Jude Amplatzer Atrial Septal Occluder (ASO): Safety Communication – Reports of Tissue Erosion AUDIENCE: Cardiology, Risk Manager, Patient ISSUE: FDA is alerting health care providers and patients that in … Continue reading

Share
Posted in Cardiology, FDA 2013, FDA Notice, FDA Safety Communication, Patients, Risk Manager | Tagged , , , , , , , , , , , | Comments Off on St Jude Amplatzer Atrial Septal Occluder ASO Safety Communication

Engström Ventilator Aespire View Aisys And Avance Anesthesia Machines

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseEngström Ventilator, Aespire View, Aisys, And Avance Anesthesia Machines: Voluntary Field Corrective Action – Potential Safety Issue AUDIENCE: Risk Manager, Anesthesiology, Health Professional ISSUE: GE Healthcare has initiated a voluntary … Continue reading

Share
Posted in Anesthesiology, FDA 2013, FDA Recall, Healthcare Professionals, Risk Manager | Tagged , , , , , , , , , , , , , , | Comments Off on Engström Ventilator Aespire View Aisys And Avance Anesthesia Machines

Avance Aisys And Avance CS2 Anesthesia Delivery Systems

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseAvance, Aisys And Avance CS2 Anesthesia Delivery Systems: Voluntary Field Corrective Action – Potential Safety Issue AUDIENCE: Risk Manager, Anesthesiology, Health Professional ISSUE: GE Healthcare has initiated a voluntary field … Continue reading

Share
Posted in Anesthesiology, FDA 2013, FDA Notice, Healthcare Professionals, Risk Manager | Tagged , , , , , , , , , , , , , | Comments Off on Avance Aisys And Avance CS2 Anesthesia Delivery Systems

Inclusig Ponatinib Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseInclusig (Ponatinib): Drug Safety Communication – Increased Reports Of Serious Blood Clots In Arteries And Veins AUDIENCE: Health Professional, Oncology ISSUE: FDA is investigating an increasing frequency of reports of … Continue reading

Share
Posted in FDA 2013, FDA Safety Communication, Healthcare Professionals, Oncology | Tagged , , , , , , , , | Comments Off on Inclusig Ponatinib Drug Safety Communication

Arzerra ofatumumab and Rituxan rituximab Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseArzerra (ofatumumab) and Rituxan (rituximab): Drug Safety Communication – New Boxed Warning, Recommendations to Decrease Risk of Hepatitis B Reactivation AUDIENCE: Oncology, Pharmacy, Rheumatology, Patient ISSUE: FDA approved changes to … Continue reading

Share
Posted in FDA 2013, FDA Safety Communication, Oncology, Patients, Pharmacy, Rheumatology | Tagged , , , , , , , , , , , , , , | Comments Off on Arzerra ofatumumab and Rituxan rituximab Drug Safety Communication